Press Releases
Aetna 2027 Medicare plans offer reliable, affordable access to care & member support
Plans designed to provide member value and access to care: $0 copays on Tier 1 drugs and covered vaccines at in-network pharmacies* $0 copays for annual physicals, colonoscopies and mammograms at in-network providers $0 copays for annual Healthy Home Visit from a licensed Signify Health clinician Dental, vision and hearing benefits A continued focus on affordability, quality care and preserving the benefits that matter most to members through an expanded HMO portfolio and market-leading coverage of generic drugs Targeted care for high-needs members with chronic conditions and those dually eligible for Medicare and Medicaid Award-winning guidance and support for our members delivered through our dedicated service teams and market-leading digital tools WOONSOCKET, R.I., Oct. 3, 2026 /PRNewswire/ -- Aetna, a CVS Health company (NYSE: CVS), today announced our 2027 Medicare products with choices designed to support older adults with a wide range of health needs, providing reliable benefits that enable affordability and access to quality care...
Edge Total Intelligence Announces Debt Modification, Impairment of Intangibles and Goodwill, and Austal Business Update
Arlington, Virginia--(Newsfile Corp. - October 2, 2026) - Edge Total Intelligence Inc. (TSXV: CTRL) (OTCQB: UNFYF) ("edgeTI" or the "Company") announces the restructuring of certain debt obligations, an impairment of intangible assets and goodwill to be applied to its Q2 2026 financial statements, and an update on project work with Austal Limited ("Austal"). All amounts are in U.S. dollars unless otherwise indicated...
Jaguar Health Announces a Special Stock Dividend
Dividend intended to provide dilution protection to Jaguar shareholders as company continues evaluation of strategic alternatives SAN FRANCISCO, CA / ACCESS Newswire / October 2, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company") today announced that its Board of Directors has declared a special stock dividend (the "Special Stock Dividend") to holders of Jaguar Common Stock and certain outstanding warrants as of record on October 13, 2026. The Special Stock Dividend will consist of the Company's Series R Convertible Preferred Stock (the "Preferred Stock")...
Purecore Announces Up to $2.5 Million Non-Brokered Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (OTCQB: PPURF) (“Purecore” or the “Company”) is pleased to announce that it intends to complete a non-brokered private placement for aggregate gross proceeds of up to C$2,500,000 (the “Offering”). The Offering will consist of a combination of hard dollar units of the Company (the “HD Units”) at a price of C$1.35 per HD Unit and flow-through units of the Company (the “FT Units”) at a price of C$1.50 per FT Unit...
ORVANA ANNOUNCES AMENDMENT TO OSP PREPAYMENT FACILITY
TSX: ORV OTCQX: ORVMF TORONTO, Oct. 2, 2026 /PRNewswire/ -- Orvana Minerals Corp. (TSX: ORV) (OTCQX: ORVMF) (the "Company" or "Orvana") announces that its Bolivian subsidiary, Empresa Minera Paitití, S.A. ("EMIPA"), has entered into an amendment (the "Amendment") to its US$25 million secured prepayment facility with Trafigura Pte...
ARCF IV Participates in US$5.7 million Registered Direct Offering
For dissemination in Canada and over Canadian news services only TORONTO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Arias Resource Capital Fund IV L.P. (“ARCF IV”) announced that it has agreed to invest US$1,299,999.68 (the “Investment”) in units (“Units”) of Largo Inc. (“Largo” or the “Issuer”) (TSX: LGO) (NASDAQ: LGO)...
Plato Gold Corp. Closes Initial $55,000 Tranche of Critical-Mineral Flow-Through Private Placement
/ NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / / NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES /
FLOWERS FOODS ISSUES RECALL OF NATURE'S OWN HAWAIIAN BREAD DUE TO UNDECLARED MILK
THOMASVILLE, Ga., Oct. 2, 2026 /PRNewswire/ -- Flowers Foods, Inc. (NYSE: FLO) is recalling Nature's Own Hawaiian Bread, 20 oz.
World Copper Announces Closing of Non-Brokered Private Placement and Shares for Debt Settlement
Vancouver, British Columbia--(Newsfile Corp. - October 2, 2026) - World Copper Ltd. (TSXV: WCU) (OTCQB: WCUFF) (FSE: 7LY2) ("World Copper" or the "Company") announces that it has closed its previously announced non-brokered private placement (the "Offering") pursuant to which the Company issued 13,333,329 units (the "Units") at a price of $0.075 per Unit for aggregate gross proceeds of approximately $1,000,000...
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced that on October 1, 2026, the Compensation Committee of the Company's Board of Directors (the “Compensation Committee”) granted inducement awards consisting of nonstatutory stock options to purchase 6,000 shares of common stock to a...
Graphano Energy Provides Update on Proposed Earn-In Transaction with 3D Genesis Technologies
Vancouver, British Columbia--(Newsfile Corp. - October 2, 2026) - Graphano Energy Ltd. (TSXV: GEL) (OTC Pink: GELEF) (FSE: 97G0) ("Graphano" or the "Company") announces that, further to its news releases dated June 26, 2026, July 29, 2026 and August 31, 2026, the 90-day period provided under its binding memorandum of understanding dated June 25, 2026 (the "MOU") with 3D Genesis Technologies ("3D Genesis") for the parties to enter into a definitive agreement in respect of the proposed earn-in transaction (the "Transaction") relating to the APIC metal additive manufacturing technology (the "Technology") has expired and the Company has determined not to proceed with the Transaction at this time...
Silvercorp Reports 2026 Annual General and Special Meeting Results
Trading Symbol: TSX/NYSE American: SVM VANCOUVER, BC, Oct. 2, 2026 /PRNewswire/ -- Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American: SVM) is pleased to report that all matters submitted to shareholders for approval as set out in the Company's Notice of Meeting and Information Circular, both dated August 12, 2026, and the news releases issued on September 22 and September 30, 2026, were approved by the requisite majority of votes cast at Silvercorp's annual general and special meeting (the "Meeting") held today. A total of 123,182,474 common shares, representing 55.69% of the votes attached to all outstanding shares as at the record date for the Meeting, were represented at the Meeting...
SOBR Provides Update and Explores Potential Options
SOBR Provides Clarity and Considers Future Options DENVER, CO / ACCESS Newswire / October 2, 2026 / SOBR Safe, Inc. (NASDAQ:SOBR) ("SOBRsafe" or the "Company"), is issuing this press release as certain news has been put forth which the Company believes requires it to clarify SOBR's position. The Company is exploring and considering its options moving forward, but no decision has been made by the Company's Board of Directors or its stockholders to dissolve the Company...
World Acceptance Corporation Data Breach Exposes Personal Information: Murphy Law Firm Investigates Legal Claims
OKLAHOMA CITY, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Murphy Law Firm is investigating claims on behalf of all individuals whose personal and confidential information was compromised in the data breach involving World Acceptance Corporation. To join the class action lawsuit, visit our site HERE.
Global Compliance Applications Corp. Closes First Tranche of Private Placement
Vancouver, British Columbia--(Newsfile Corp. - October 2, 2026) - Global Compliance Applications Corp. (CSE: APP) (FSE: TK6) (OTC Pink: FUAPF) ("GCAC" or the "Company") announces that pursuant to its news release issued September 17, 2026, the Company has closed the first tranche of its Private Placement and will issue 41,000,000 Units @ $0.005 per Unit for gross proceeds of CAD$205,000. Each Unit consists of one common share (a "Share") and one common share purchase warrant (a "Warrant)...
Integra LifeSciences Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Integra LifeSciences (IART)
A $4.3 million to $6.3 million gap between Integra's preliminary third-quarter revenue and the Wall Street estimate sent IART shares lower. SueWallSt notifies investors of a pending investigation into potential securities claims for shareholders who lost money.
Sixty North Gold Announces Debt Settlements and Option Grants
Vancouver, British Columbia--(Newsfile Corp. - October 2, 2026) - Sixty North Gold Mining Ltd. (CSE: SXTY) (FSE: 2F40) (OTC Pink: SXNTF) (the "Company" or "Sixty North Gold") announces that that it has arranged debt settlements with certain officers and directors of the Company to settle a total of $130,000 in indebtedness for accrued management and consulting fees from the period October 1, 2025 to September 30, 2026, to be settled by the issuance and delivery of a total of 928,570 common shares of the Company at a price of $0.14 per share within the next five (5) business days subject to the CSE raising no objection to such closing...
McFarlane Files Updated Mineral Resource Estimate on Juby Gold Project
Key Highlights 1.07 million indicated ounces of gold at 0.96 g/t contained in 34.68 million tonnes 1 5.09 million inferred ounces of gold at 0.87 g/t contained in 183.05 million tonnes 1 This represents a 61% increase in inferred resources and a 6% increase in indicated resources from previous technical report having an effective date of September 29, 2025 Overall gold recoveries at 92% New drilling permit extends drilling program to August 2029 Two more drills are being added this month Filed Technical Report reflects a minor amendment where inferred resources have increased by 30,000 ounces and indicated resources decreased by 70,000 ounces to the estimate announced August 17, 2026 See note 1 below Table 1 TORONTO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- McFarlane Lake Mining Limited (“McFarlane” or the “Company”) (CSE: MLM, OTC: MLMLF), a Canadian gold exploration and development company, is pleased to announce the filing of an updated Mineral Resource Estimate (“MRE”) for its Juby Gold project (“Juby”) located in the prolific Abitibi Belt in Ontario, Canada. The Technical Report, prepared in accordance with NI 43-101, is now available under the Company's issuer profile on SEDAR+ and on its website...
NOMAD POWER SOLUTIONS ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS
BOCA RATON, Fla., Oct. 02, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions, Inc. ("NOMAD" or the "Company") (Nasdaq: NMAD) (formerly LIXTE Biotechnology Holdings), a provider of transportable, utility-grade battery energy storage systems through its wholly owned subsidiary NOMAD Transportable Power Systems, today announced that its Special Meeting of Stockholders (the “Special Meeting”), reconvened on October 2, 2026, was adjourned without conducting any business. The Special Meeting will reconvene on October 30, 2026, at 1:00 PM Eastern Time...
Bitzero Engages and Renews Investor Relations Providers to Expand Capital Markets Program
Vancouver, British Columbia--(Newsfile Corp. - October 2, 2026) - Bitzero Holdings Inc. (NASDAQ: AIBZ) (CSE: AIBZ.U) (FSE: 000) ("Bitzero" or the "Company"), a provider of sustainable high-performance compute ("HPC") and AI data center infrastructure, announced that it has engaged and renewed certain investor relations providers as the Company continues to expand its capital markets presence and broaden awareness of its Nordic infrastructure platform among the institutional and retail investment community. Pursuant to the respective contract terms detailed below, the Company has entered into agreements with the following firms for investor relations and market engagement services...
MagnaFlow Joins NFI Empire's Project REBORN, Providing 5-Inch Exhaust for The Brett Boyer Foundation Build
Every Detail Matters: MagnaFlow Helps Put the Finishing Touch on Project REBORN's 5-Inch Exhaust NORTH EAST, PA / ACCESS Newswire / October 2, 2026 / NFI Empire, a fully owned subsidiary of Newport Gold, Inc. (OTCID:NWPG), today announced that MagnaFlow has joined Project Reborn-001 as a performance partner. The custom vehicle build is heading to auction at The Red Bird Games in Brentwood, TN, with proceeds benefiting The Brett Boyer Foundation...
Portland General Electric Schedules Earnings Release and Conference Call for Thursday, October 29
Portland, Oregon--(Newsfile Corp. - October 2, 2026) - Portland General Electric Company (NYSE: POR) announced today that it will host an analyst conference call and webcast at 11 a.m. ET on Thursday, October 29, to review its third quarter 2026 financial results.
Electra Reports Quarterly Update on Capital Markets Activity
TORONTO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) reported on its capital markets activity for the previous quarter, including activity under its at-the-market equity program (“ATM”) and equity participation by employees and directors...
TrustBix Inc. Announces Management Update
Edmonton, Alberta--(Newsfile Corp. - October 2, 2026) - TrustBIX Inc. (TSXV:TBIX) ("TrustBIX" or the "Company") is pleased to announce the appointment of Haider Khan as the Company's Chief Financial Officer. The appointment of Mr.
F3 Issues Common Shares Debt Settlement of Interest Owed
Kelowna, British Columbia--(Newsfile Corp. - October 2, 2026) - F3 Uranium Corp. (TSXV: FUU) (OTCQB: FUUFF) (FSE: GL7) ("F3" or the "Company") notes that it wishes to issue common shares to Denison Mines Corp. ("Denison") (TSX: DML) (NYSE American: DNN) pursuant its financing agreement as entered into in October 2023. Denison has elected to settle a portion of the accrued interest for the past quarter with the acceptance of common shares of F3 (the "Debt Settlement")...
Provident Financial Services, Inc. Schedules Third Quarter Earnings Conference Call
ISELIN, N.J., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE: PFS) announced that it expects to release financial results for the quarter ended September 30, 2026 on Wednesday, October 28, 2026 after market close. A copy of the earnings release will be immediately available on the Company's website, www.Provident.Bank, by going to Investor Relations and clicking on Press Releases...
Quebec Rare Earth Elements Announces Adoption of Semi-Annual Reporting
Toronto, Ontario--(Newsfile Corp. - October 2, 2026) - Quebec Rare Earth Elements Corp. (CSE: QREE) ("QREE" or the "Company") announces that it has adopted the policies outlined in the Semi-Annual Reporting ("SAR") Pilot Program utilizing the exemptions provided under Coordinated Blanket Order 51-933 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers (the"BlanketOrder"). The SAR Pilot Program is implemented under the Blanket Order, which allows eligible venture issuers listed on the Canadian Securities Exchange (the "CSE") to voluntarily move from quarterly to semi-annual financial reporting...
Marfrig Global Foods S.A., through its subsidiary NBM US Holdings, Inc., announces termination of offer to purchase for cash any and all outstanding 6.625% Senior Notes due 2029
São Paulo, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Marfrig Global Foods S.A. (“MBRF”) (B3: MBRF3; ADR Level 1: MBRFY), through its subsidiary, NBM US Holdings, Inc. (“NBM” or the “Offeror”), announced today that it has terminated its previously announced offer to purchase for cash from each registered holder (each, a “Holder” and, collectively, the “Holders”) any and all of the outstanding 6.625% Senior Notes due 2029 (CUSIP Nos. 62877V AB7; U63768 AB8 / ISIN Nos. US62877VAB71; USU63768AB83) issued by NBM, with US$467,471,000 in aggregate principal amount outstanding (the “Notes” and the “Offer”, respectively), the terms and conditions of which are described in an Offer to Purchase dated September 28, 2026 (the “Offer to Purchase”), as a result of the Financing Condition (as defined below) not having been satisfied...
KinderCare Announces Board of Directors Transitions
LAKE OSWEGO, Ore.--(BUSINESS WIRE)--KinderCare Learning Companies, Inc. (“KinderCare”) (NYSE: KLC), a leading provider of high-quality early childhood education and care, today announced that Mike Nuzzo has resigned from the company's Board of Directors, effective Sept. 28, due to other personal and professional time commitments. David Barse, who joined KinderCare's Board on Aug. 3, replaces Nuzzo as the Head of the Audit Committee. Preston Grasty, Senior Investment Leader at Partners Group, ha...
Copper Lake Resources Announces Closing of First Tranche of Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - October 2, 2026) - Copper Lake Resources Ltd. (TSXV: CPL) (FSE: W0I0) (OTC Pink: WTCZF) ("Copper Lake" or the "Company") is pleased to announce the closing of the first tranche of its previously announced non-brokered private placement (September 3, 2026) (the "Private Placement")...
Chilwa Announces Closing of US$3.5 Million Offering
PERTH, Australia, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Chilwa Minerals Limited, an Australian company (ASX:CHW, NASDAQ:CHWM) (Chilwa or the Company), is pleased to announce the closing of its underwritten public offering. The offering consisted of 625,000 American Depositary Shares (“ADSs") and warrants to purchase 625,000 ADSs at an offering price of US$5.60 per ADS and accompanying warrant. Each ADS offered represents 10 ordinary shares of Chilwa. The gross proceeds, before deducting underwriter discounts and offering expenses, were US$3.5 million. The warrants have an exercise price of US$5.60 per ADS, are exercisable immediately upon issuance and expire on the fifth anniversary of the original issuance date. The ADSs began trading on the Nasdaq Capital Market under the ticker symbol “CHWM” on October 1, 2026...
Almonty Secures Corrective Disclosure from Pure Tungsten Following Successful Settlement Confirming Tiger Kim Held No Leadership Role at Almonty at Any Time
DILLON, Mont.--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company“) (NASDAQ: ALM) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, today noted that Pure Tungsten Inc. (“Pure Tungsten”) has published a clarification on its website regarding Mr. Tiger Kim's prior involvement with Almonty (the "Corrective Disclosure"), accessible at https://www.puretungsten.ca/news-1/pure-tungsten-clarification-of-tiger-kims-prior-involvement-with-almonty-industries. The Corre...
First Hawaiian to Report Third Quarter 2026 Financial Results on October 23, 2026
HONOLULU, Oct. 02, 2026 (GLOBE NEWSWIRE) -- First Hawaiian, Inc. (NASDAQ: FHB) announced today that it plans to release its third quarter 2026 financial results on Friday, October 23, 2026 before the market opens. First Hawaiian will host a conference call to discuss the company's results on the same day at 1:00 p.m. Eastern Time (7:00 a.m. Hawaii Time)...
Shift4 Announces Fifth Dividend Date for Mandatory Convertible Preferred Stock
CENTER VALLEY, Pa.--(BUSINESS WIRE)--Shift4 Payments, Inc. (“Shift4” or the “Company”) (NYSE: FOUR), announced today, in connection with the 10,000,000 shares of 6% Series A Mandatory Convertible Preferred Stock issued on May 5, 2025, consistent with the terms laid out in the offering, the Board of Directors has declared a dividend of $1.50 per share to be paid in cash on November 2, 2026 to holders of record as of the close of business on October 15, 2026. Subject to the terms of the Mandatory...
VOYA ASIA PACIFIC HIGH DIVIDEND EQUITY INCOME FUND AND VOYA EMERGING MARKETS HIGH DIVIDEND EQUITY FUND ANNOUNCE TRADING SUSPENSION IN ADVANCE OF REORGANIZATIONS
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Voya Investment Management, the asset management business of Voya Financial, Inc. (NYSE: VOYA), announced today that shareholders of Voya Asia Pacific High Dividend Equity Income Fund (NYSE: IAE) (“IAE Fund”) and Voya Emerging Markets High Dividend Equity Fund (NYSE: IHD) (“IHD Fund,” and together with IAE Fund, the “Target Funds”) approved the reorganization of each Target Fund with and into Voya Multi-Manager Emerging Markets Equity Fund (“MM EME Fund” or the “Surviving Fund”) (each, a “Reorganization” and together, the “Reorganizations”) at a combined special meeting of shareholders held on September 28, 2026...
PMET Resources Files Amended Version of its NI 43-101 Technical Report on the CV5 Lithium-Only Feasibility Study Previously Published in 2025 on its Shaakichiuwaanaan Project
Following a routine review by the Autorité des marchés financiers ("AMF"), the government agency responsible for regulating securities in the Province of Québec, Canada, the Company has filed an amended Technical Report (as defined below) correcting certain compliance-related irregularities. HIGHLIGHTS The clarification, formatting and additional disclosure in the amended Technical Report have no impact on the economic or technical conclusions of the 2025 Lithium-only FS (as defined below) which remain as previously stated...
Azincourt Energy Completes Harrier Prospecting Program and Commences Drilling at Snegamook Uranium Deposit
Vancouver, British Columbia--(Newsfile Corp. - October 2, 2026) - AZINCOURT ENERGY CORP. (TSXV: AAZ) (OTCQB: AZURF) (FSE: A0U0) ("Azincourt" or the "Company"), is pleased to provide an update on the 2026 work program at the Harrier Project in the Central Mineral Belt in Labrador, Canada.
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that on October 1, 2026, the Compensation Committee of Xeris' Board of Directors granted non-qualified stock options and restricted stock units for an aggregate of 352,170 shares of its common stock to 60 new employees under Xeris' Inducement Equity Plan...
Novo provides update on the denecimig Biologics License Application (BLA) in the US
Bagsværd, Denmark, 02 October 2026 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has informed Novo that the BLA review of denecimig for the treatment of haemophilia A, with or without inhibitors in adults and children, is still ongoing. The FDA has not communicated a new timeline for expected regulatory action on the BLA...
Pinnacle West Sets Date for 2026 Third-Quarter Financial Results, Webcast/Conference Call
PHOENIX--(BUSINESS WIRE)--Pinnacle West Capital Corp. (NYSE: PNW) announced today that it plans to release its 2026 third-quarter financial results before U.S. financial markets open on Tuesday, Nov. 3, 2026. That same day at 11 a.m. (9 a.m. Arizona time), management will host a live webcast and conference call to discuss financial results and recent developments. To access the live session: Join the webcast at www.pinnaclewest.com/presentations for audio of the call and slides; or Dial (888) 5...
Fidelity Investments Canada (FGQE) Closes the Market
Toronto, Ontario--(Newsfile Corp. - October 2, 2026) - Andrew Clee, Vice President, Product & Managed Accounts, Fidelity Investments Canada ("Fidelity" or the "Company") and his team, joined Keith Wu, Head, Exchange Traded Products, Toronto Stock Exchange ("TSX"), to close the market and celebrate the launch of the Company's new ETF product: Fidelity Global Quant Equity ETF (TSX: FGQE) Cannot view this video? Visit: https://www.youtube.com/watch?v=0IIRTz3sjAE Fidelity offers investors and institutions a range of innovative and trusted investment products, including mutual funds and exchange-traded funds, to help them reach their financial and life goals...
iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026
Following completion of the forensic investigation, company begins notifying impacted individuals Following completion of the forensic investigation, company begins notifying impacted individuals
AtlasClear Holdings Announces Long-Term Stock Option Awards to Support Leadership Retention and Shareholder Alignment
TAMPA, Fla., Oct. 02, 2026 (GLOBE NEWSWIRE) -- AtlasClear Holdings, Inc. (NYSE American: ATCH) (“AtlasClear” or the “Company”), a company building regulated financial infrastructure for smaller institutions, fintechs and advisors, today announced that its Compensation Committee and Board of Directors approved long-term stock option awards for members of the Company's executive leadership team and Board of Directors...
Catheter Precision to Change its Name and Ticker Symbol to Flyte Aviation and “VJET” and Effect 1-for-10 Reverse Stock Split, Monday, October 5, at Market Open
Changes highlight the Company's growth trajectory as a leading private, regional jet aviation business Changes highlight the Company's growth trajectory as a leading private, regional jet aviation business
Mineralys Therapeutics Announces Presentation of New Lorundrostat Data at the American Society of Nephrology (ASN) Kidney Week 2026
RADNOR, Pa., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney disease, obstructive sleep apnea and other diseases driven by dysregulated aldosterone, today announced that new data from the Launch-HTN trial of lorundrostat will be presented at the American Society of Nephrology Kidney Week 2026, taking place October 21-25 in Denver, Colorado...
Surge Announces Positive Pre-Feasibility Study at Nevada North: After-Tax NPV8% of US$9.81 Billion, After-Tax IRR of 23.6% and Operating Cost of US$4,719/tonne Lithium Carbonate
PFS improves on 2025 PEA with lower Phase 1 capital, lower operating cost, higher recovery and a faster 4.2-year payback over a 42-year mine life West Vancouver, British Columbia--(Newsfile Corp. - October 2, 2026) - Surge Battery Metals Inc. (TSXV: NILI) (OTCQX: NILIF) (FSE: DJ5) ("Surge" or the "Company") is pleased to announce the results of the Pre-Feasibility Study ("PFS") for the Nevada North Lithium Project ("NNLP", "Nevada North" or the "Project") located in Elko County, Nevada. The Project is held by Nevada North Lithium LLC ("NNL"), a joint venture owned 67.5% by Surge and 32.5% by Evolution Mining Limited ("Evolution Mining")...
Kenorland Completes Top-Up Right from Sumitomo and Centerra
Vancouver, British Columbia--(Newsfile Corp. - October 2, 2026) - Kenorland Minerals Ltd. (TSXV: KLD) (OTCQX: KLDCF) (FSE: 3WQ0) ("Kenorland" or the "Company") announces that, further to its press release dated September 18, 2026, the Company, Sumitomo Metal Mining Canada Ltd.
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on October 1, 2026 (the “Grant Date”), ORIC granted a total of 161,550 non-qualified stock options and 26,850 restricted stock units to six new non-executive employees who began their employment with ORIC in September 2026...
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today announced that on September 30, 2026, the Compensation Committee of the Company's Board of Directors (the “Compensation Committee”) granted inducement awards consisting of 90,775 restricted stock units (“RSUs”) and 32,725 non-qualified stock options (“NSOs”) to three newly hired non-executive employees. The foregoing inducement awards were granted as inducements material to the new employees entering into employment with Imagene in accordance with Nasdaq Listing Rule 5635(c)(4), and are subject to the terms and conditions of the Company's 2025 Equity Inducement Plan and the applicable equity award agreements...
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced that, effective October 1, 2026, the company granted non-qualified stock options to purchase an aggregate of 100,895 shares of its common stock to two new employees under Xilio Therapeutics' Third Amended and Restated 2022 Inducement Stock Incentive Plan (the 2022 Inducement Stock Incentive Plan). Additionally, the company granted a non-qualified stock option to purchase 105,000 shares of its common stock under the 2022 Inducement Stock Incentive Plan to the company's newly appointed Chief Medical Officer, Yariv Houvras, M.D., Ph.D...
Pershing Square Declares Fourth Quarter 2026 Dividend
NEW YORK--(BUSINESS WIRE)--Pershing Square Inc. (NYSE:PS) (“Pershing Square” or the “Company”) today announced that its Board of Directors (the “Board”) has declared a quarterly cash dividend of $0.103 per share of its common stock for the fourth quarter of 2026, payable on October 20, 2026 to shareholders of record as of the close of business on October 12, 2026. The declaration and amount of any future quarterly cash dividends are at the sole discretion of the Board and may be variable from q...
National Healthcare Properties Announces Conversion of Class A Common Stock into Common Stock
NEW YORK, Oct. 02, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHP) (the “Company”) announced today that, as previously disclosed, all outstanding shares of its Class A common stock, $0.01 par value per share (“Class A common stock”), will automatically convert into its common stock, $0.01 par value per share (“common stock”), on a one-for-one basis. All shares of common stock will begin trading on the Nasdaq Global Market, effective at 9:30 a.m. Eastern time on October 19, 2026. The conversion will have no effect on the economic rights of holders of shares of Class A common stock and the Company's operations...
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company granted stock options to six new employees to purchase an aggregate of 235,950 shares of the Company's common stock, effective as of October 1, 2026. These awards were approved by the Compensation Committee of Olema's Board of Directors and granted under the Company's 2022 Inducement Plan as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4)...
Bank of Marin Bancorp to Webcast Q3 Earnings on Monday, October 26, 2026, at 8:30 a.m. PT
NOVATO, Calif.--(BUSINESS WIRE)--Bank of Marin Bancorp to Webcast Q3 Earnings on Monday, October 26, 2026, at 8:30 a.m. PT.
Vertical Aerospace Receives Continued Listing Standard Notice from NYSE
NEW YORK & LONDON--(BUSINESS WIRE)--Vertical Aerospace (“Vertical” or the “Company”) [NYSE: EVTL], a global aerospace and technology company pioneering electric vertical take-off and landing (“eVTOL”) aircraft, today announced that it received a notice from the New York Stock Exchange (the “NYSE”) on September 9, 2026, indicating that the Company is not currently in compliance with the NYSE continued listing standard requiring a minimum average closing price for its ordinary shares of $1.00 over...
Voyageur Pharmaceuticals Announces Completion of Shares for Debt Settlement
Calgary, Alberta--(Newsfile Corp. - October 2, 2026) - Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) ("Voyageur" or the "Company"), a Canadian developer of pharmaceutical-grade barium and iodine contrast media for medical imaging, is pleased to announce that, further to the Company's news release dated September 24, 2026, the Company has completed its previously announced shares for debt settlement, in settlement of outstanding indebtedness in the aggregate amount of $192,300 (the "Debt") through the issuance of common shares of the Company ("Common Shares") at a deemed price of $0.155 per Common Share...
Ares Management Corporation Updates the Time of Its Earnings Conference Call for the Third Quarter Ending September 30, 2026
NEW YORK, Oct. 2, 2026 /PRNewswire/ -- Ares Management Corporation announced today that it has updated the time it will hold its earnings webcast/conference call for the third quarter ending September 30, 2026 to 9:00am ET on Thursday, October 29, 2026. Ares Management Corporation will report its earnings for the third quarter ending September 30, 2026 earlier that morning, prior to the opening of the New York Stock Exchange...
Extra Space Storage Inc. Announces Date of Earnings Release and Conference Call to Discuss 3rd Quarter Results
SALT LAKE CITY, Oct. 2, 2026 /PRNewswire/ -- Extra Space Storage Inc. (the "Company") (NYSE: EXR) announced today it will release financial results for the three and nine months ended September 30, 2026, on Tuesday, October 27, 2026, after the market closes. The Company will host a conference call at 1:00 p.m...
Southport Acquisition Corp. II Announces Completion of Its Initial Public Offering
Greenwich, CT, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Southport Acquisition Corp. II (NYSE: PORT.U) (the “Company”) today announced the closing of the Company's initial public offering of 21,000,000 units, which includes 1,000,000 units issued pursuant to the partial exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit...
NeuroSense Provides Update on Nasdaq Listing Compliance
Company regains compliance with Nasdaq's minimum bid price requirement and intends to request a Nasdaq Hearings Panel hearing to seek additional time to regain compliance with the minimum market value requirement CAMBRIDGE, Mass., Oct. 2, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd.
Celanese to Hold Third Quarter Earnings Conference Call on November 3, 2026
DALLAS--(BUSINESS WIRE)--Celanese to Hold Third Quarter Earnings Conference Call on November 3, 2026.
Arcosa, Inc. Announces Commencement of Bondholder Calls
DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, today announced it will hold quarterly bondholder calls for the benefit of the holders of the Notes, the Trustee, beneficial owners of the Notes, prospective purchasers of the Notes, securities analysts and market making financial institutions to ask questions following the release of its quarterly financial information, beginning with the Quarterly Report...
RITE Reduces Potential Dilution by Nearly 2 Billion Shares and Caps the Series NMC Sinking-Fund Obligation
Dallas, Texas--(Newsfile Corp. - October 2, 2026) - MineralRite Corporation (OTCID: RITE) today announced that it has completed a transaction that reduces the potential dilution that would have resulted from full exercise of the Series NMC warrants without a repurchase and establishes a contractual ceiling on the total amount payable under the sinking fund for the Series NMC Preferred Stock. Repurchase of nearly 3.9 million Series NMC Preferred shares reduces potential dilution by nearly 2 billion shares When RITE acquired the three leases and tailings from NMC, Inc., it issued 6.9 million Series NMC Preferred shares and warrants to acquire an additional 6.9 million Series NMC Preferred shares...
KBRA Assigns Preliminary Ratings for RRE 11 Loan Management DAC (Reset)
LONDON--(BUSINESS WIRE)-- #creditratingagency--KBRA UK (KBRA) assigns preliminary ratings to five classes of refinancing Notes issued by RRE 11 Loan Management DAC, a cash flow collateralised loan obligation (CLO) backed primarily by a diversified portfolio of Euro-denominated corporate loans. RRE 11 Loan Management DAC is managed by Redding Ridge Asset Management (UK) LLP ("RRAM UK" or the "collateral manager"). The CLO will have a 4.5-year reinvestment period and a 15.0-year legal final. The ratings reflect initia...
BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) Announces Distribution
NEW YORK--(BUSINESS WIRE)--BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) today announced a distribution of $0.0500 per share of common stock, payable on November 2, 2026 to shareholders of record at the close of business on October 19, 2026. The ex-dividend date is October 19, 2026. The previous distribution announced in September was $0.0500 per share of common stock. The Fund intends to make regular monthly distributions to its common shareholders at a level rate based on it...
SEALSQ's Sister Company, WISeSat.Space, Completes Business Combination with Columbus Acquisition Corporation
Geneva, Switzerland, Oct. 02, 2026 (GLOBE NEWSWIRE) -- WISeSat.Space Ordinary Shares Begin Trading on Nasdaq Under Ticker Symbol “SAIQ”
Pasqal Appoints Roger L. Chuchen as Head of Investor Relations
PARIS and NEW YORK, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Pasqal (NASDAQ: PSQL), a global leader in neutral-atom quantum computing, today announced the appointment of Roger L. Chuchen as Head of Investor Relations, as the company expands its commercial operations and global customer base following its Nasdaq listing in August 2026...
PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DELRAY BEACH, Fla., Oct. 02, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced that PetMeds recently granted equity awards previously approved by its Board of Directors to two newly hired executives as a material inducement to employment...
Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028
PLANO, Texas, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028 (the “Notes”) that the Notes are convertible, at the option of the holders (the “Conversion Option”) beginning on October 1, 2026, and ending at the close of business on December 31, 2026. The Notes are convertible into cash, up to the principal amount of the Notes, and in cash, shares of the Company's common stock or a combination thereof, at the Company's election, in respect of the remainder, if any, of the Company's conversion obligation in excess of the aggregate principal amount of the Notes being converted...
Allison Completes Partial Redemption of 4.750% Senior Notes due 2027
INDIANAPOLIS, Oct. 2, 2026 /PRNewswire/ -- Allison Transmission Holdings, Inc. (NYSE: ALSN) ("Allison" or the "Company") announced the completion of its partial redemption of $100 million aggregate principal amount of its 4.750% Senior Notes due 2027 (the "notes") on September 30, 2026 (the "redemption date"), pursuant to its optional redemption right under the indenture governing the notes, dated as of September 26, 2017. On the redemption date, the notes were redeemed at a redemption price of 100.00% of the principal amount thereof plus accrued and unpaid interest to, but not including, the redemption date...
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, today announced that the Compensation Committee of Spero's Board of Directors approved grants, made on October 1, 2026, of an aggregate of 233,000 restricted stock unit awards (RSUs) and 323,000 stock options to new employees under the Spero Therapeutics, Inc. 2019 Inducement Equity Incentive Plan, as amended (2019 Inducement Plan). The stock options and RSUs are being granted as an inducement material to Spero's new employees in accordance with Nasdaq Listing Rule 5635(c)(4)...
Surf Air Mobility Announces Employee Inducement Awards Under NYSE Rule 303A.08
LOS ANGELES--(BUSINESS WIRE)--Surf Air Mobility Inc. (“Surf Air Mobility” or the “Company”) (NYSE: SRFM), a leading air mobility platform, today announced that it granted inducement awards to two new employees in reliance on the employment inducement exemption under the NYSE's Listed Company Manual Rule 303A.08. The Company is issuing this press release pursuant to the requirements of that rule. On October 2, 2026, the Company granted awards to Jason Secore in connection with Mr. Secore's comme...
Safe Bulkers, Inc. Declares Quarterly Dividend on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares; 8.00% Series D Cumulative Redeemable Perpetual Preferred Shares
MONACO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (the “Company”) (NYSE/Euronext Athens: SB), an international provider of marine drybulk transportation services, announced today that the Company's Board of Directors has declared:
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.0833 per Share
MIAMI, Oct. 02, 2026 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) declares its monthly distribution for October 2026 of $0.0833 per share, comprised of an $0.08 per share base dividend and $0.0033 per share supplemental dividend, payable on November 2, 2026 to stockholders of record as of October 15, 2026. The distribution is expected to be paid from taxable net investment income. The final specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year and in the Company's periodic report filed with the Securities and Exchange Commission...
Rush Enterprises, Inc. Conference Call Advisory for Third Quarter 2026 Earnings Call
NEW BRAUNFELS, Texas, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Rush Enterprises, Inc., (NASDAQ: RUSHA & RUSHB), which operates the largest network of commercial vehicle dealerships in North America will host a conference call to discuss earnings for the third quarter 2026 on Wednesday, October 28, 2026 at 10:00 a.m. Eastern/9:00 a.m...
Spyre Therapeutics Announces Grants of Inducement Awards
WALTHAM, Mass., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater durability, and a simpler treatment experience for patients, today announced that Spyre's independent Compensation Committee of the Board of Directors approved the grant of stock options to purchase an aggregate of 21,424 shares of common stock of Spyre and 6,604 restricted stock units (“RSUs”) to two non-executive employees as equity inducement awards under the Spyre Therapeutics, Inc. 2018 Equity Inducement Plan, as amended (the “2018 Plan”). The stock options and RSUs were approved on October 1, 2026 and were material to each employee's acceptance of employment with Spyre, in accordance with Nasdaq Listing Rule 5635(c)(4)...
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) (“Apnimed” or the “Company”), a late-stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases, today announced that on October 1, 2026, the compensation committee of Apnimed's board of directors granted 19 new non-executive employees non-qualified stock options to purchase an aggregate of 481,300 shares of the Company's common stock under Apnimed's 2026 Inducement Plan (the “Plan”). Each stock option granted has an exercise price per share of $22.54, which is equal to Apnimed's closing trading price on the grant date. One-fourth of the shares underlying each of the employee's stock options will vest on the first anniversary of each employee's start date and in equal monthly installments thereafter for the next three years, subject to such employee's continued employment with the Company on such vesting dates...
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
MIAMI, Oct. 02, 2026 (GLOBE NEWSWIRE) -- PennantPark Investment Corporation (the "Company") (NYSE: PNNT) declares its monthly distribution for October 2026 of $0.08 per share, comprised of a $0.04 per share base dividend and $0.04 per share supplemental dividend, payable on November 2, 2026 to stockholders of record as of October 15, 2026. The distribution is expected to be paid from taxable net investment income. The final specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year and in the Company's periodic report filed with the Securities and Exchange Commission...
Covenant Logistics Group, Inc. Announces Timing of Third Quarter Earnings Release and Conference Call
CHATTANOOGA, Tenn., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Covenant Logistics Group, Inc. (NYSE: CVLG) announced its plans to release its third quarter earnings after 4:00 p.m. Eastern time on Thursday, October 29, 2026. Covenant Logistics Group, Inc. will hold a live conference call to discuss its third quarter earnings release on Friday, October 30, 2026, at 10:00 a.m. Eastern time. Individuals with questions may dial in at 877-550-1505 (U.S./Canada) and 0800-524-4760 (International). An audio replay will be available for one week following the call at 800-645-7964, access code 3895#. In addition, you will be able to listen to the audio replay for an extended period of time on our investor website, under the icon "Audio Archives". For additional financial and statistical information regarding the Company that may be discussed during the conference call, please visit our website at www.covenantlogistics.com/investors under “Earnings Info.”
WISeQey's Subsidiary WISeSat.Space, a Space Technology Company, Completes Business Combination with Columbus Acquisition Corporation
WISeQey's Subsidiary WISeSat.Space, a Space Technology Company, Completes Business Combination with Columbus Acquisition Corporation
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on September 29, 2026, the Compensation Committee of the Board of Directors (Compensation Committee) of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to purchase 16,700 shares of Class A common stock and restricted stock units (RSUs) underlying 8,350 shares of Class A common stock to five (5) new employees under the Inducement Plan...
Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today announced that on October 1, 2026, one new employee was granted an inducement award consisting of a stock option to purchase 60,000 shares of common stock...
Block to Announce Third Quarter 2026 Results
DISTRIBUTED-WORK-MODEL/OAKLAND, Calif.--(BUSINESS WIRE)--Block, Inc. (NYSE: XYZ) will release financial results for the third quarter of 2026 on Tuesday, November 3, 2026, after market close. Block will also host a conference call and earnings webcast at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on the same day to discuss these results. To register to participate in the conference call, or to listen to the live audio webcast, please visit the Events & Presentations section of Block's...
Sixth Street Specialty Lending, Inc. Schedules Earnings Release and Conference Call to Discuss its Third Quarter Ended September 30, 2026 Financial Results
NEW YORK--(BUSINESS WIRE)--Sixth Street Specialty Lending, Inc. (NYSE: TSLX) (“TSLX” or “the Company") announced today that it will release its financial results for the third quarter ended September 30, 2026 on Tuesday, November 3, 2026, after the market closes. TSLX invites all interested persons to its webcast / conference call on Wednesday, November 4, 2026 at 8:30 a.m. Eastern Time to discuss these results. Conference Call Information: The conference call will be broadcast live in listen-o...
Caesars Entertainment, Inc. to Release 2026 Third Quarter Results on October 27, 2026
LAS VEGAS & RENO, Nev.--(BUSINESS WIRE)--Caesars Entertainment, Inc. (NASDAQ: CZR) (“Caesars”, “the Company”) will release its financial results for the third quarter after the market closes on Tuesday, October 27, 2026. Considering the Company's pending merger with Fertitta Entertainment announced on May 28, 2026, Caesars will not host an earnings call. Upon completion of the proposed merger agreement, Caesars' common stock will no longer be listed on NASDAQ, and the Company will become a priv...
Bank of Hawai‘i Corporation Conference Call to Discuss Third Quarter 2026 Financial Results and Board Declares Quarterly Preferred Stock Dividends
HONOLULU--(BUSINESS WIRE)--Bank of Hawai‘i Corporation (NYSE: BOH) (the “Company”) will release third quarter 2026 financial results on Monday, October 26, 2026 before the market opens and hold its quarterly conference call at 2:00 p.m. Eastern Time (8:00 a.m. Hawai‘i Time) on the same day. The live call, including a slide presentation, will be accessible on the investor relations link of the Company's website, www.boh.com. The conference call link is https://register-conf.media-server.com/regi...
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the grant of inducement equity awards to five newly hired non-executive employees as a material inducement to commencing their employment with the Company. The employees received, in the aggregate, non-qualified stock options to purchase 86,725 shares of Monte Rosa Therapeutics common stock, par value $0.0001 per share, with an exercise price per share equal to the closing price of $11.26 as reported by Nasdaq on October 1, the effective date of the grant or the “Grant Date”, which will vest 25% on the first anniversary of the Grant Date and in 36 equal monthly installments thereafter, subject to the employee's continued service with the Company through each applicable vesting date; and restricted stock units for an aggregate of 19,150 shares of Monte Rosa Therapeutics common stock, which will vest 25% on each of the first four anniversaries of the Grant Date, subject to the employee's continued service with the Company through each applicable vesting date, or collectively, the Awards...
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, BC and BOSTON, MA, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced equity inducement grants to eight new non-officer employees consisting of an aggregate of 17,850 share options and 10,500 restricted share units (RSUs). All of the foregoing share options and RSUs were approved by the Compensation Committee of the Company's Board of Directors with an effective date of October 1, 2026 and were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4)...
Teknova and Pluristyx Announce FDA Drug Master File for the PluriFreeze™ Cryopreservation System
Teknova and Pluristyx announce a Type II FDA Drug Master File for the PluriFreeze™ cryopreservation system, now available to developers for cross-reference
Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CARLSBAD, Calif., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that on September 28, 2026, it granted stock options to purchase 180,137 shares of the Company's common stock and 89,286 time-based restricted stock units (“RSUs”) to Richard Heppenstall, the Company's newly-hired Chief Financial Officer, as a material inducement to his employment...
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NAARDEN, The Netherlands and MIAMI, Oct. 02, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam's Board of Directors approved the grant of inducement share options covering an aggregate of 71,800 of NewAmsterdam's ordinary shares to 7 non-executive new hires. The share options were granted as an inducement material to the employees' acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4)...
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that on October 1, 2026, the Compensation Committee of Praxis' Board of Directors granted restricted stock unit awards covering an aggregate of 3,478 shares of its common stock to fourteen new non-executive employees under the Praxis Precision Medicines, Inc. 2024 Inducement Plan (the 2024 Inducement Plan). The restricted stock unit awards were granted as inducements material to the employees' entering into employment with Praxis in accordance with Nasdaq Listing Rule 5635(c)(4)...
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEW YORK, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on October 1, 2026, the Company granted inducement awards to purchase up to 213,300 shares of common stock to nine new employees under the Company's 2023 Inducement Plan. The stock options will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the vesting commencement date and 1/48th of the underlying shares vesting monthly thereafter over 36 months, subject to the employee's continued service relationship with Syndax through the applicable vesting dates...
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced that on October 1, 2026, it awarded inducement grants to eight new employees under Intellia's 2024 Inducement Plan, as amended, as a material inducement to employment...
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WILMINGTON, Del., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), today announced that the Company granted non-qualified stock options to purchase up to an aggregate of 128,000 shares of the Company's common stock to two newly-hired non-executive employees under the Company's 2026 Inducement Equity Plan (the “Inducement Plan”), effective as of September 30, 2026 (the “Effective Date”). The inducement grants were previously approved by the Compensation Committee of the Company's Board of Directors, as a material inducement to the new employees' entry into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4)...
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the grant of an aggregate of 62,500 restricted stock units (RSUs) of Arcutis common stock to six newly hired employees. These awards were approved by the Compensation Committee of Arcutis' Board of Directors and granted under the Arcutis Biotherapeutics, Inc. 2022 Inducement Plan, with a grant date of October 1, 2026, as a material inducement to the new employees in connection with their commencement of employment with Arcutis, in accordance with Nasdaq Listing Rule 5635(c)(4)...